Brii Biosciences Limited

HK$1.04As of Sun 8 Nov 2026, 12:00 UTC
HKEX:2137Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 5Y CAGR (45.28%)
Div yield —
ROE (7.67%)
Biotechnology
Beta (5Y) 1.72
PE TTM —
TSR TTM (42.86%)
Mkt cap HK$750.7M
ROIC (7.13%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.12
7.95%
(54.49%)
Hold 1|9|4|2|5
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.02
0.02
0.02
0.02
12.01%
13.24%
14.38%
7.25%
Revenue¥M
31.37
33.03
32.30
34.10
(0.03%)
4.16%
4.78%
13.15%
Peers (US$95.76M)
Cap (US$)
PE
81.72M
—
Capital
TTM
5Y
10Y
Leveragex
2.745
0.069
0.051
EBIT/Intx
3.314
0.104
0.108
Own earn%
(82.41)
(22.12)
(22.51)
Sh yield%
44.98
46.45
46.02
Owners
Insiders/Inst%
6.51
70.71
Short interest%
4.80
SBC / revenue%
5.85
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
13
Op margin range%
16–20
$1 testx
0.0
Incr. ROIC%
80